VA
CEMI

Valmark Advisers’s Chembio diagnostics, Inc. CEMI Stock Holding History

Valmark Advisers’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,413
Closed -$11.3K – 487
2022
Q4 		$11.3K Hold
51,413
– – ﹤0.01% 443
2022
Q3 		$19K Hold
51,413
– – ﹤0.01% 409
2022
Q2 		$33K Hold
51,413
– – ﹤0.01% 404
2022
Q1 		$42K Hold
51,413
– – ﹤0.01% 422
2021
Q4 		$59K Hold
51,413
– – ﹤0.01% 405
2021
Q3 		$129K Hold
51,413
– – ﹤0.01% 388
2021
Q2 		$153K Buy
+51,413
New +$179K ﹤0.01% 386

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Valmark Advisers's CEMI Position: Q1 2023 in Review

Valmark Advisers sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 51,413 shares — an estimated $11.3K sold.

Valmark Advisers first reported a position in CEMI in Q2 2021 and held it in 7 quarters. The position peaked at $153K in Q2 2021. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Valmark Advisers reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Valmark Advisers sold 51,413 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $11.3K.
  • Valmark Advisers first reported a position in Chembio diagnostics, Inc. in Q2 2021 and held it in 7 quarters.
  • Valmark Advisers's Chembio diagnostics, Inc. position peaked at $153K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Valmark Advisers's 13F filing for Q1 2023, filed 2 May 2023.